Patterns of Outpatient and Acute Care Use Among Patients with SLE on Long-Term Moderate to High Dose Glucocorticoid Medication: A 1 Year Retrospective Analysis

被引：0
|
作者：
Sullivan, James [1 ]
Littlejohn, Emily [2 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland Hts, OH USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1452
引用
收藏
页码：2865 / 2868
页数：4
相关论文
共 50 条
  • [11] Long-Term Impact of Fremanezumab on Response Rate, Acute Headache Medication Use, and Disability in Chronic Migraine Patients with Acute Medication Overuse at Baseline: Results of a 1-Year Study
    Silberstein, S. D.
    Kudrow, D.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 113 - 113
  • [12] Epidemiology of psychiatric medication use in patients recovering from critical illness at a long-term acute-care facility
    Weinert, CR
    CHEST, 2001, 119 (02) : 547 - 553
  • [13] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine: Results of a 1-Year Study
    Brandes, Jan
    Marmura, Michael
    Yeung, Paul
    Cohen, Joshua
    Gandhi, Sanjay
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [14] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Chronic Migraine: Results of a 1-Year Study
    McAllister, P.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    HEADACHE, 2019, 59 : 114 - 114
  • [15] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine: Results of a 1-Year Study
    Brandes, J.
    Marmura, M. J.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    HEADACHE, 2019, 59 : 122 - 122
  • [16] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients With Chronic Migraine: Results of a 1-Year Study
    McAllister, Peter
    Yeung, Paul P.
    Cohen, Joshua
    Gandhi, Sanjay
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [17] Reductions in Acute Medication Use for Patients with Migraine Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis
    Krasenbaum, Lynda J.
    Driessen, Maurice T.
    Seminerio, Michael J.
    DiEgidio, Robert
    Tian, Marc
    NEUROLOGY, 2022, 98 (18)
  • [18] Antipsychotic Prescribing Patterns, and the Factors and Outcomes Associated with Their Use, Among Patients Requiring Prolonged Mechanical Ventilation in the Long-Term Acute Care Hospital Setting
    Al-Qadheeb, Nada S.
    O'Connor, Heidi H.
    White, Alexander C.
    Neidhardt, Aura
    Albizati, Mark
    Joseph, Bernard
    Roberts, Russel J.
    Ruthazer, Robin R.
    Devlin, John W.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (02) : 181 - 188
  • [19] Long-Term term efficacy of fremanezumab in chronic and episodic migraine patients with acute medication overuse at baseline: results of a 1-year study
    Silberstein, Stephen D.
    Ashina, Messoud
    Cohen, Joshua M.
    Seminerio, Michael J.
    Yang, Ronghua
    Ning, Xiaoping
    Blaiss, Cory
    CEPHALALGIA, 2019, 39 : 234 - 235
  • [20] Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with episodic migraine: interim results of a 1-year study
    Brandes, Jan L.
    Yeung, Paul P.
    Cohen, Joshua M.
    Gandhi, Sanjay K.
    Fitzgerald, Timothy
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
12345